Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Update

Pulmatrix, Inc. (NASDAQ:PULMGet Free Report) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 39,500 shares, a drop of 47.3% from the December 15th total of 74,900 shares. Based on an average daily volume of 461,600 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.1% of the shares of the stock are short sold.

Pulmatrix Trading Down 1.5 %

NASDAQ PULM traded down $0.09 on Tuesday, reaching $5.90. 26,235 shares of the company were exchanged, compared to its average volume of 57,242. Pulmatrix has a fifty-two week low of $1.55 and a fifty-two week high of $8.44. The business’s fifty day moving average price is $5.67 and its 200 day moving average price is $3.35. The stock has a market capitalization of $21.55 million, a P/E ratio of -2.23 and a beta of 1.52.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Pulmatrix in a research report on Sunday, January 5th. They set a “hold” rating for the company.

Check Out Our Latest Report on Pulmatrix

About Pulmatrix

(Get Free Report)

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Featured Stories

Receive News & Ratings for Pulmatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmatrix and related companies with MarketBeat.com's FREE daily email newsletter.